Background
Uveitis, or inflammation of the uvea, is classified clinically into infectious and non-infectious groups [
1]. Infectious uveitis is triggered by a wide range of exogenous factors. In contrast, non-infectious uveitis is an inflammatory response that is triggered by certain environmental factors in individuals with a particular genetic component. Non-infectious uveitis is an autoimmune process by which there is a loss of tolerance against self-antigens. Certain HLA alleles have been found to be strongly associated with uveitis [
2].
In up to 50% of the cases, autoimmune uveitis precedes or follows the onset of an autoimmune disease. Some of the associated autoimmune diseases include the spondyloarthritides, Behçet’s disease, Vogt-Koyanagi-Harada (VKH) syndrome, systemic lupus erythematosus, sarcoidosis, autoimmune hepatitis, and multiple sclerosis [
3]. There is ample evidence that most autoimmune disease share a certain percentage of their genetic component, suggesting that some pathologies may be influenced by a common pathway. The interleukin-23 receptor (IL-23R) belongs to a well-established group of risk factors (shared by different conditions) that influence the breakdown of self-tolerance [
4].
The IL-23R gene is located on chromosome 1p31. It is highly expressed in dendritic cells, and is involved in several chronic inflammatory diseases [
5]. Several single-nucleotide polymorphisms (SNPs) in IL-23R have been found to be associated with chronic inflammatory diseases, including inflammatory bowel disease, ankylosing spondylitis, and psoriasis. Recent studies found that IL-23R gene polymorphisms are associated with uveitis in Behçet’s disease and sarcoidosis [
6,
7]. However, other studies found no significant association between uveitis and IL-23R gene polymorphisms [
5,
8].
Three of several polymorphisms of IL-23R have been studied in some detail. These include rs7517847, rs17375018, and rs11209032. However, the results from different studies have been inconsistent. The aim of this meta-analysis was to investigate the genetic association between IL-23R polymorphisms and the susceptibility to non-infectious uveitis.
Discussion
In this study, we addressed the association between IL-23R polymorphisms and susceptibility to uveitis. Data from published studies were combined to evaluate the genetic associations between the most commonly studied polymorphisms of IL-23R, rs7517847, rs17375018, and rs11209032, and uveitis.
There was no significantly association between the rs7517847 polymorphism and uveitis. The rs17375018 polymorphism was also not associated with uveitis, except the AA + AG vs. GG genotype. Although results of the rs17375018 A allele, AA vs. AG + GG genotype, and AA vs. GG genotype showed no significant association with uveitis, the A allele tended to decrease uveitis (OR 0.68, 95% CI 0.47–0.99, P = 0.05; OR 0.76, 95% CI 0.49–1.18, P = 0.22; OR 0.56, 95% CI 0.29–1.09, P = 0.09). In the present meta-analysis, combined evidence demonstrated that the IL23R gene rs11209032 polymorphisms were not associated with uveitis. However, the rs11209032 AA genotype was significantly associated with uveitis. We found that the homozygote models, including the rs17375018 GG genotype and rs11209032 AA genotype, were significantly associated with uveitis.
Many theories on the etiology of Fuchs’ syndrome have been suggested including viral infection, toxoplasmosis, vascular abnormality, and autoimmunity. Some studies have shown that infections such as rubella virus and toxoplasma could lead to the development of Fuchs’ syndrome. However, other studies found that patients with Fuchs’ syndrome had high levels of proinflammatory cytokines, the pathology of the iris was rich in CD8+ lymphocytes, and the aqueous humor had abundant oligoclonal IgG production. These findings indicate that Fuchs’ syndrome has immunologic characteristics. Thus, we performed this meta-analysis with and without Fuchs’ syndrome. The results showed that there was no association between IL23R polymorphisms and uveitis.
Th17 cells may be relevant to human uveitis. Transfer of Th17 cells led to neutrophilic infiltrates, which is consistent with the cytokine and chemokine profile typical of the respective responses [
16]. Th17 cells bind to proinflammatory cytokines such as IL-1, IL-6, transforming growth factor β (TGF-β), IL-21, and IL-23. IL-23 activity is mediated by its binding to the IL-23R on 17 helper T (Th17) cells. The IL23-Th17 interactions are thought to play an important role in the development of autoimmune disease [
7]. IL-23 is a heterodimeric regulatory cytokine that is produced by activated macrophages and dendritic cells. IL-23 induces a cell population with a unique inflammatory gene signature. This signature includes IL-17A, IL-17F, IL-6, colony-stimulating factor 2 (CSF2), tumor necrosis factor (TNF), CC-chemokine ligand 20 (CCL20), CCL22, IL-1 receptor type 1 (IL-1R1), and IL-23R [
17].
IL-23 was found to be elevated in VKH syndrome and Behçet’s disease [
18,
19]. Some previous studies also showed an association between SNPs in IL-23R and uveitis. However, the results varied based on the accompanying systemic disease or cause of uveitis [
5,
6]. This study analyzed the association between the rs7517847, rs17375018, and rs11209032 polymorphisms and uveitis. However, some studies showed significant associations between uveitis and other polymorphisms of IL-23R, such as rs924080and rs117633859 [
20,
21].
The strength of our meta-analysis could be summarized as follows. We attempted to identify as many publications as possible using various search techniques. To the best of our knowledge, our study is the first meta-analysis regarding overall uveitis. It includes uveitis of ankylosing spondylitis, Behçet’s disease, VKH syndrome, sarcoidosis, Fuchs’ syndrome, and any other endogenous non anterior uveitis. All studies satisfied HWE. This implies that there was no potential bias regarding the control selection or genotyping errors.
This study also has several limitations. First, there was significant heterogeneity in some comparisons. There was variability in both diseases of developing uveitis as well as ethnicity. Unfortunately, stratification for ethnicity was not possible due to the low number of published studies on this topic. In addition, because only English publications were included, there may have been a language bias. A third limitation is that publication bias may have affected the analysis, because studies that produced negative results may not have been published or may have been missed. Fourth, we did not conduct a meta-analysis of haplotype analysis; however, haplotype analysis may have provided more information and would have been more powerful than single polymorphism analysis. Fifth, we did not classify the cases into anterior uveitis, posterior uveitis, and panuveitis. Lastly, although IL-23R polymorphisms may be associated with disease severity and susceptibility, we did not perform a meta-analysis for this association.